These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes. Dampier CD, Smith WR, Kim HY, Wager CG, Bell MC, Minniti CP, Keefer J, Hsu L, Krishnamurti L, Mack AK, McClish D, McKinlay SM, Miller ST, Osunkwo I, Seaman P, Telen MJ, Weiner DL, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN). Am J Hematol; 2011 Dec; 86(12):E70-3. PubMed ID: 21953763 [Abstract] [Full Text] [Related]
9. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD). Tanabe P, Silva S, Bosworth HB, Crawford R, Paice JA, Richardson LD, Miller CN, Glassberg J. Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145 [Abstract] [Full Text] [Related]
10. A comparison of two regimens of patient-controlled analgesia for children with sickle cell disease. Trentadue NO, Kachoyeanos MK, Lea G. J Pediatr Nurs; 1998 Feb; 13(1):15-9. PubMed ID: 9503762 [Abstract] [Full Text] [Related]
11. Pain experience of children with sickle cell disease who had prolonged hospitalizations for acute painful episodes. Jacob E, Mueller BU. Pain Med; 2008 Feb; 9(1):13-21. PubMed ID: 18254762 [Abstract] [Full Text] [Related]
12. A novel approach to pain management in persons with sickle cell disease. Myers M, Eckes EJ. Medsurg Nurs; 2012 Feb; 21(5):293-8. PubMed ID: 23243787 [Abstract] [Full Text] [Related]
13. Approach to the vaso-occlusive crisis in adults with sickle cell disease. Yale SH, Nagib N, Guthrie T. Am Fam Physician; 2000 Mar 01; 61(5):1349-56, 1363-4. PubMed ID: 10735342 [Abstract] [Full Text] [Related]
14. Patient-controlled analgesia for sickle cell pain crisis in a pediatric emergency department. Melzer-Lange MD, Walsh-Kelly CM, Lea G, Hillery CA, Scott JP. Pediatr Emerg Care; 2004 Jan 01; 20(1):2-4. PubMed ID: 14716157 [Abstract] [Full Text] [Related]
15. Body Mass Index and the Association With Vaso-occlusive Crises in Pediatric Sickle Cell Disease. Zivot A, Apollonsky N, Gracely E, Raybagkar D. J Pediatr Hematol Oncol; 2017 May 01; 39(4):314-317. PubMed ID: 28221266 [Abstract] [Full Text] [Related]
16. Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis. Payne J, Aban I, Hilliard LM, Madison J, Bemrich-Stolz C, Howard TH, Brandow A, Waite E, Lebensburger JD. Pediatr Blood Cancer; 2018 Dec 01; 65(12):e27420. PubMed ID: 30151977 [Abstract] [Full Text] [Related]
17. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department. García-Morin M, López-Sangüos C, Vázquez P, Alvárez T, Marañón R, Huerta J, Cela E. Hemoglobin; 2016 Nov 01; 40(6):388-391. PubMed ID: 28361592 [Abstract] [Full Text] [Related]
18. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease. Ender KL, Krajewski JA, Babineau J, Tresgallo M, Schechter W, Saroyan JM, Kharbanda A. Pediatr Blood Cancer; 2014 Apr 01; 61(4):693-6. PubMed ID: 24249617 [Abstract] [Full Text] [Related]
19. Patient-Controlled Analgesia vs Intravenous Push Hydromorphone for Pain Management of Vaso-Occlusive Crisis Associated With Sickle Cell Disease. Russo K, Chhunchha P. J Pain Palliat Care Pharmacother; 2023 Jun 01; 37(2):116-122. PubMed ID: 36701332 [Abstract] [Full Text] [Related]
20. [Analgesic efficacy of topical lidocaine for vaso-occlusive crisis in children with sickle cell disease]. Rasolofo J, Poncelet M, Rousseau V, Marec-Berard P. Arch Pediatr; 2013 Jul 01; 20(7):762-7. PubMed ID: 23731603 [Abstract] [Full Text] [Related] Page: [Next] [New Search]